Earnings History Data for Taro Pharmaceutical Industries Ltd. (TARO) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 20-05-2024 | AH | TARO | Taro Pharmaceutical Industries Ltd. | 1,590 | 0.43 | 0.31 | 0.18 | Taro Pharmaceutical GAAP EPS of $0.40 beats by $0.09, revenue of $164.94M beats by $8.88M [5/20/2024 5:25 PM] |
42.60 | 0.18 (0.42%) |
42.60 | 0.18 (0.42%) |
28.10 - 45.76 | 14,478 | 20,000 | 382 | ||
| 25-01-2024 | AH | TARO | Taro Pharmaceutical Industries Ltd. | 1,580 | 0.56 | 0.30 | 0.19 | Taro Pharmaceutical GAAP EPS of $0.54 beats by $0.24, revenue of $157.15M beats by $2.24M [1/25/2024 5:14 PM] |
43.31 | -0.02 (-0.03%) |
43.75 | 0.42 (0.97%) |
22.89 - 45.76 | 125,244 | 60,000 | 115 | ||
| 26-10-2023 | AH | TARO | Taro Pharmaceutical Industries Ltd. | 1,260 | 0.38 | 0.18 | -0.07 | Taro Pharmaceutical GAAP EPS of $0.23, revenue of $148.2M [10/26/2023 5:07 PM] |
32.80 | -0.74 (-2.21%) |
33.54 | 0.0 (0.00%) |
22.89 - 42.22 | 12,433 | 20,000 | 463 | ||
| 26-07-2023 | PM | TARO | Taro Pharmaceutical Industries Ltd. | 1,410 | 0.40 | 0.31 | 0.37 | Taro Pharmaceutical Non-GAAP EPS of $0.40 beats by $0.09, revenue of $158.9M beats by $9.87M [7/27/2023 5:45 AM] |
36.80 | 0.04 (0.11%) |
36.76 | 0.0 (0.00%) |
22.89 - 42.22 | 30,244 | 60,000 | 439 | ||
| 23-05-2023 | PM | 6:40 PM ET (May 23) |
TARO | Taro Pharmaceutical Industries Ltd. | 1,090 | 0.18 | 0.23 | 0.73 | Taro Pharmaceutical misses top and bottom line consensus for Q1 [5/24/2023 3:47 AM] |
29.12 | -1.85 (-5.97%) |
30.97 | 0.0 (0.00%) |
22.89 - 40.15 | 17,356 | 40,000 | 219 | |
| 24-01-2023 | AH | 6:40 PM ET (Jan 24) |
TARO | Taro Pharmaceutical Industries Ltd. | 1,170 | 0.19 | 0.87 | 0.70 | Taro Pharmaceutical GAAP EPS of $0.19 misses by $0.68, revenue of $139.2M misses by $23.92M [1/24/2023 6:03 PM] |
30.38 | -0.47 (-1.52%) |
0.0 | 0.0 (0.00%) |
27.50 - 51.08 | 12,886 | 10,000 | 0 | |
| 27-10-2022 | PM | 5:30 PM ET (Oct 27) |
TARO | Taro Pharmaceutical Industries Ltd. | 1,230 | -0.07 | 0.84 | 0.66 | Taro Pharmaceutical Non-GAAP EPS of $0.66 misses by $0.18, revenue of $130.5M misses by $30.52M [10/28/2022 2:07 AM] |
32.52 | -0.47 (-1.44%) |
32.85 | 0.0 (0.00%) |
28.25 - 62.22 | 82,951 | 20,000 | 178 | |
| 26-05-2022 | PM | 5:15 PM ET (May 26) |
TARO | Taro Pharmaceutical Industries Ltd. | 1,350 | 0.73 | 0.88 | 0.81 | Taro Pharmaceutical GAAP EPS of $0.73, revenue of $143.26M [5/27/2022 2:10 AM] |
36.80 | 1.59 (4.50%) |
0.0 | 0.0 (0.00%) |
33.59 - 76.00 | 74,198 | 30,000 | 0 | |
| 27-01-2022 | AH | 5:15 PM ET (Jan 27) |
TARO | Taro Pharmaceutical Industries Ltd. | 1,770 | 0.70 | 0.91 | 0.86 | Taro Pharmaceutical GAAP EPS of $0.70 misses by $0.21, revenue of $138.98M misses by $3.24M [1/27/2022 5:02 PM] |
48.22 | 1.04 (2.22%) |
0.0 | 0.0 (0.00%) |
43.29 - 80.00 | 12,712 | 20,000 | 0 | |
| 28-10-2021 | AH | 7:30 PM ET (Oct 28) |
TARO | Taro Pharmaceutical Industries Ltd. | 2,300 | 0.66 | 1.02 | 1.18 | Taro Pharmaceutical EPS misses by $0.36, misses on revenue [10/28/2021 5:32 PM] |
56.24 | -3.60 (-6.02%) |
0.0 | 0.0 (0.00%) |
55.42 - 80.00 | 30,613 | 10,000 | 0 | |
|
||||||||||||||||||
| 27-07-2021 | PM | 5:30 PM ET (Jul 27) |
TARO | Taro Pharmaceutical Industries Ltd. | 2,670 | 1.09 | 0.84 | 0.76 | Taro Pharmaceutical EPS beats by $0.25, beats on revenue [7/28/2021 1:01 AM] |
72.36 | 1.62 (2.29%) |
0.0 | 0.0 (0.00%) |
53.95 - 80.00 | 19,395 | 30,000 | 0 | |
| 19-05-2021 | AH | TARO | Taro Pharmaceutical Industries Ltd. | 2,800 | 0.81 | 0.92 | 1.42 | Taro Pharmaceutical EPS misses by $0.11, beats on revenue [5/19/2021 5:44 PM] |
70.89 | -0.47 (-0.66%) |
0.0 | 0.0 (0.00%) |
53.95 - 80.00 | 16,024 | 20,000 | 0 | ||
| 27-01-2021 | AH | 5:15 PM ET (Jan 27) |
TARO | Taro Pharmaceutical Industries Ltd. | 2,940 | 0.86 | 1.01 | 1.76 | Taro Pharmaceutical EPS misses by $0.15, misses on revenue [1/27/2021 5:52 PM] |
71.61 | 1.13 (1.60%) |
0.0 | 0.0 (0.00%) |
53.95 - 83.19 | 26,637 | 24,759 | 0 | |
| 28-10-2020 | AH | 5:00 PM ET (Oct 28) |
TARO | Taro Pharmaceutical Industries Ltd. | 2,300 | 1.18 | 0.77 | 1.46 | Taro Pharmaceutical EPS beats by $0.41, beats on revenue [10/28/2020 5:18 PM] |
58.85 | 1.07 (1.85%) |
61.73 | 0.0 (0.00%) |
53.95 - 99.69 | 14,126 | 26,668 | 658 | |
|
|
||||||||||||||||||
| 29-07-2020 | AH | 5:30 PM ET (Jul 29) |
TARO | Taro Pharmaceutical Industries Ltd. | 2,490 | 0.76 | 1.49 | 1.72 | Taro Pharmaceutical EPS of -$11.37 [7/29/2020 5:04 PM] |
61.86 | -6.13 (-9.02%) |
0.0 | 0.0 (0.00%) |
56.07 - 99.69 | 44,033 | 28,867 | 0 | |
|
|
||||||||||||||||||
| 19-05-2020 | AH | TARO | Taro Pharmaceutical Industries Ltd. | 2,520 | 1.42 | 1.53 | 1.52 | Taro Pharmaceutical EPS misses by $0.11, beats on revenue [5/19/2020 5:33 PM] |
67.18 | -0.33 (-0.49%) |
0.0 | 0.0 (0.00%) |
56.07 - 102.28 | 39,892 | 33,434 | 0 | ||
|
|
||||||||||||||||||